GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer.
暂无分享,去创建一个
[1] R. Silverman,et al. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers , 2011, Oncogene.
[2] Reid F. Thompson,et al. DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis , 2011, Mammalian Genome.
[3] C. Eng,et al. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. , 2011, Cancer letters.
[4] R. Silverman,et al. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines , 2010, Human molecular genetics.
[5] O. Feron,et al. The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism , 2010, Oncogene.
[6] J. Kench,et al. A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes , 2009, Oncogene.
[7] Brian J. Wilson,et al. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis , 2009, Oncogene.
[8] M. Shakibaei,et al. Resveratrol addiction: to die or not to die. , 2009, Molecular nutrition & food research.
[9] Y. Wang,et al. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival , 2008, Oncogene.
[10] Katsunobu Sakurai,et al. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers , 2008, International Journal of Clinical Oncology.
[11] C. Eng,et al. Regulation of the PTEN promoter by statins and SREBP. , 2007, Human molecular genetics.
[12] Y. Wang,et al. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells , 2007, Oncogene.
[13] Matthias Frisch,et al. Androgen receptor binding sites identified by a GREF_GATA model. , 2005, Journal of molecular biology.
[14] C. Eng,et al. Phytoestrogen exposure elevates PTEN levels. , 2005, Human molecular genetics.
[15] M. Federici,et al. Phosphorylation of GATA2 by Akt Increases Adipose Tissue Differentiation and Reduces Adipose Tissue–Related Inflammation: A Novel Pathway Linking Obesity to Atherosclerosis , 2005, Circulation.
[16] D. Troyer,et al. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. , 2005, Endocrine-related cancer.
[17] Paul E Swanson,et al. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. , 2003, American journal of clinical pathology.
[18] Charis Eng,et al. PTEN: One Gene, Many Syndromes , 2003, Human mutation.
[19] T. Mak,et al. Regulation of PTEN transcription by p53. , 2001, Molecular cell.
[20] M. Rosenfeld,et al. Reciprocal Interactions of Pit1 and GATA2 Mediate Signaling Gradient–Induced Determination of Pituitary Cell Types , 1999, Cell.
[21] Ross Ihaka,et al. Gentleman R: R: A language for data analysis and graphics , 1996 .
[22] S. Orkin,et al. GATA-binding transcription factors in hematopoietic cells. , 1992, Blood.
[23] K. Hagino-Yamagishi,et al. [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.